A recent study points to a possibility that in T cells of type 2 diabetes patients, mRNA level of MAP4K4 might be affected by enhanced methylation of CpG islands in its promoter region [17], suggesting epigenetic regulation could play a role in the regulation of MAP4K4 expression. Here, MAP4K4 is linked to type 2 diabetes mellitus.